# IBUPROFEN
> **ANDA214789** · Abbreviated New Drug Application (Generic) · Sponsor: PAI HOLDINGS PHARM · Approved 2024-11-08
## Drug
- **FDA Application Number:** ANDA214789
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBUPROFEN
- **Generic name:** IBUPROFEN
- **Active ingredients:** IBUPROFEN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** PAI HOLDINGS PHARM
- **Manufacturer:** PAI Holdings, LLC dba PAI Pharma
- **First approval:** 2024-11-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214789)
---
*AI Analytics · CC0 1.0*